INZY logo

Inozyme Pharma (INZY) Company Overview

Profile

Full Name:

Inozyme Pharma, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 24, 2020

Indexes:

Not included

Description:

Inozyme Pharma (INZY) is a biotechnology company focused on developing innovative treatments for rare genetic diseases. They specialize in enzyme replacement therapies to address unmet medical needs, aiming to improve patients' lives through advanced science and research. Their work targets conditions related to mineral metabolism and other disorders.

Events Calendar

Earnings

Next earnings date:

Mar 12, 2025

Recent quarterly earnings:

Nov 5, 2024

Recent annual earnings:

Mar 12, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 13, 25 Wells Fargo
Overweight
Jan 13, 25 Piper Sandler
Overweight
Jan 13, 25 HC Wainwright & Co.
Buy
Jan 10, 25 HC Wainwright & Co.
Buy
Nov 6, 24 Needham
Buy
Nov 6, 24 HC Wainwright & Co.
Buy
Oct 25, 24 Needham
Buy
Oct 25, 24 HC Wainwright & Co.
Buy
Sep 30, 24 Wedbush
Outperform
Sep 12, 24 Stifel
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Inozyme Pharma?
  • Does Inozyme Pharma pay dividends?
  • What sector is Inozyme Pharma in?
  • What industry is Inozyme Pharma in?
  • What country is Inozyme Pharma based in?
  • When did Inozyme Pharma go public?
  • Is Inozyme Pharma in the S&P 500?
  • Is Inozyme Pharma in the NASDAQ 100?
  • Is Inozyme Pharma in the Dow Jones?
  • When was Inozyme Pharma's last earnings report?
  • When does Inozyme Pharma report earnings?
  • Should I buy Inozyme Pharma stock now?

What is the ticker symbol for Inozyme Pharma?

The ticker symbol for Inozyme Pharma is NASDAQ:INZY

Does Inozyme Pharma pay dividends?

No, Inozyme Pharma does not pay dividends

What sector is Inozyme Pharma in?

Inozyme Pharma is in the Healthcare sector

What industry is Inozyme Pharma in?

Inozyme Pharma is in the Biotechnology industry

What country is Inozyme Pharma based in?

Inozyme Pharma is headquartered in United States

When did Inozyme Pharma go public?

Inozyme Pharma's initial public offering (IPO) was on July 24, 2020

Is Inozyme Pharma in the S&P 500?

No, Inozyme Pharma is not included in the S&P 500 index

Is Inozyme Pharma in the NASDAQ 100?

No, Inozyme Pharma is not included in the NASDAQ 100 index

Is Inozyme Pharma in the Dow Jones?

No, Inozyme Pharma is not included in the Dow Jones index

When was Inozyme Pharma's last earnings report?

Inozyme Pharma's most recent earnings report was on Nov 5, 2024

When does Inozyme Pharma report earnings?

The next expected earnings date for Inozyme Pharma is Mar 12, 2025

Should I buy Inozyme Pharma stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions